Time Out: Jazz dismisses final patent claim involving cannabinoid epilepsy drug
MJ Biz reports Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex. The Ireland-based company, according to […]